Home / Blog – MesotheliomaHelp.org / Additional Research Shows Drug in Clinical Trial Stops Growth of Pleural Mesothelioma

Additional Research Shows Drug in Clinical Trial Stops Growth of Pleural Mesothelioma

In January, MesotheliomaHelp reported that the UK Medicine and Healthcare Products Regulatory Agency designated nintedanib a Promising Innovative Medicine for the treatment of malignant pleural mesothelioma. Prior  results of a Phase II clinical trial for the drug, that will now move into a Phase III trial, showed “promising activity” against pleural mesothelioma. Now, researchers conducting a separate study with the drug report it “shows promising effectiveness” in stopping mesothelioma tumors. Researchers from Austria, Germany and Hungary conducted preclinical testing of nintedanib in human mesothelioma cell lines in vitro as well as in mouse models, according to a May 16 article […]

The post Additional Research Shows Drug in Clinical Trial Stops Growth of Pleural Mesothelioma appeared first on MesotheliomaHelp.org.



from Blog – MesotheliomaHelp.org https://ift.tt/2KHOdSC
via IFTTT
Additional Research Shows Drug in Clinical Trial Stops Growth of Pleural Mesothelioma Additional Research Shows Drug in Clinical Trial Stops Growth of Pleural Mesothelioma Reviewed by Unknown on May 21, 2018 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.